Biotech

All Articles

Lilly blog posts more good records on its once a week blood insulin prospect

.On the heels of an FDA rejection for its own primary competing Novo Nordisk, Eli Lilly is actually ...

IN 8bio standstills period 2 trial, lays off half of labor force

.Simply a few months after application the initial person in a stage 2 trial for recently detected g...

Lilly, Haya ink $1B biobuck obesity contract to explore darker genome

.Eli Lilly's look for being overweight intendeds has led it to the black genome. The Big Pharma has ...

ArsenalBio elevates $325M, turns far from previous lead possession

.Arsenal Biosciences is actually moving on up. The cell therapy business has added on $325 million i...

Lilly- supported weight management biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...

Aelis' cannabis use medication fails phase 2b, driving Indivior to reassess $100M option

.Aelis Farma's chances of getting an easy, favorable choice on a $one hundred thousand choice paymen...

ProKidney standstills stage 3 trial not required for cell therapy confirmation

.ProKidney has actually stopped one of a set of period 3 trials for its tissue treatment for kidney ...

Vaxcyte climbs on 'stunning' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what experts called "remarkable" phase 1/2 data for its own 31-valent pneumococcal...

Recursion's brain illness trial reveals scant evidence of efficacy

.Recursion has actually discovered via an early exam of its own tech-enabled method to medication di...

Acepodia, Pfizer click on with each other for chemistry-based tissue therapy

.Phone it an instance of excellent chemistry: Acepodia, a biotech based on Nobel Prize-winning scien...